Kinevac

Kinevac is a brand name of sincalide, approved by the FDA in the following formulation(s):

KINEVAC (sincalide - injectable; injection)

• 
  Manufacturer: BRACCO
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): 0.005MG/VIAL ^[RLD]

Has a generic version of Kinevac been approved?

No. There is currently no therapeutically equivalent version of Kinevac available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Kinevac. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Sincalide formulations
  Patent 6,803,046
  Issued: October 12, 2004
  Inventor(s): Edmund C.; Metcalfe & Jo Anna; Monteferrante & Margaret; Newborn & Irene; Ropiak & Ernst; Schramm & Gregory W.; White & Julius P.; Zodda
  Assignee(s): Bracco International B.V.
  The invention features sincalide formulations that include an effective amount of sincalide, a bulking agent/tonicity adjuster, a stabilizer, a surfactant, a chelator, and a buffer. The invention also features kits and methods for preparing improved sincalide formulations, as well as methods for treating, preventing, and diagnosing gall bladder-related disorders using sincalide formulations.
  
  Patent expiration dates:
  
  
  • August 16, 2022
    
    ✓ 
    Drug product
  
  

See also...

• Kinevac Consumer Information (Cerner Multum)
• Kinevac Advanced Consumer Information (Micromedex)
• Sincalide Consumer Information (Cerner Multum)
• Sincalide Intravenous Advanced Consumer Information (Micromedex)